- not yet recruitingPHASE2
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
This study looks at using heat treatment (hyperthermia) with repeat radiation therapy for certain cancers that have come back after earlier radiation. It checks if this combined approach works as well as the first treatment for preventing the cancer from returning locally.
Germany - active not recruitingPHASE1
IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor
This study is testing a new medicine, IMA401, for people with advanced cancers that have come back or haven't responded to other treatments. We want to see if it's safe, how well people tolerate it, and if it can help shrink tumours, either alone or with another cancer drug called pembrolizumab.
Germany - recruitingPHASE1, PHASE2
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
This study is testing a new medicine, IMA402, for adults with advanced or returning solid cancers that haven't responded to other treatments. We want to see if it's safe, what dose works best, and if it can help shrink tumours.
Germany · Netherlands - recruitingPHASE2
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
This study looks at a medicine called cabozantinib for patients who had liver cancer, received a liver transplant, and then their cancer came back. It aims to see how well cabozantinib works to control the cancer.
Canada - recruitingPHASE1, PHASE2
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
This study looks at new ways to treat cancer in children and teenagers (up to 21 years old). It uses information from a patient's cancer cells to choose the best medicines, aiming for more personalised and effective treatments.
Australia · Canada